Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-May-23 7:44 AM View:  | Jounce Therapeutics, Inc. (JNCE) | 03-May-23 | Disposition (change in control) | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 01-Jul-21 7:00 PM View: | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 8,126 | -- | -- | 5% 155.91K to 164.03K | |
| 18-Dec-20 4:29 PM View: | Intellia Therapeutics, Inc. (NTLA) | 17-Dec-20 | Option Exercise | 88,764 | $18.45 | $1,637,840.00 | 1775% 5.0K to 93.76K | |
| 18-Dec-20 4:29 PM View: | Intellia Therapeutics, Inc. (NTLA) | 17-Dec-20 | Market Option Sale (Planned) | 88,764 | $53.55 | $4,753,680.00 | (95%) 93.76K to 5.0K | (16%) |
| 23-Apr-19 4:15 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 80,500 | -- | -- | (100%) 80.5K to 0 | |
| 28-Feb-18 4:45 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 26-Feb-18 | Grant | 70,500 | -- | -- | 705% 10.0K to 80.5K | |
| 07-Jun-17 6:18 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 05-Jun-17 | Market Purchase | 10,000 | $3.46 | $34,588.00 | 100% 0 to 10.0K | (73%) |
| 05-Jun-17 8:01 AM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jun-17 | Grant | 5,000 | $11.98 | $59,925.00 | 100% 0 to 5.0K | 418% |
| 02-Feb-17 5:03 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-17 | Market Purchase | 5,000 | $16.00 | $80,000.00 | 100% 0 to 5.0K | (59%) |
| 18-Dec-15 4:21 PM View: | Celgene Corporation (CELG) | 17-Dec-15 | Payment of Exercise | 3,888 | $112.17 | $436,117.00 | (5%) 71.96K to 68.07K | 19% |
| 18-Dec-15 4:21 PM View: | Celgene Corporation (CELG) | 17-Dec-15 | Option Exercise | 7,500 | -- | -- | 12% 64.46K to 71.96K | |
| 02-Feb-16 4:49 PM View: | Celgene Corporation (CELG) | 22-Oct-15 | Gift | 1,000 | -- | -- | (1%) 68.07K to 67.07K | |
| 21-Jul-15 1:27 PM View: | Neoprobe Corp. (NAVB) | 16-Jul-15 | Disposition | 22,000 | $0.01 | $220.00 | (37%) 59.53K to 37.53K | |
| 15-May-15 4:29 PM View: | Celgene Corporation (CELG) | 13-May-15 | Option Exercise | 30,470 | $48.94 | $1,491,300.00 | 37% 83.16K to 113.63K | |
| 04-May-15 7:15 PM View: | Celgene Corporation (CELG) | 30-Apr-15 | Payment of Exercise | 5,807 | $108.06 | $627,504.00 | (7%) 88.97K to 83.16K | 16% |
| 04-May-15 7:15 PM View: | Celgene Corporation (CELG) | 30-Apr-15 | Option Exercise | 11,200 | -- | -- | 14% 77.77K to 88.97K | |
| 30-Mar-15 4:13 PM View: | Neoprobe Corp. (NAVB) | 26-Mar-15 | Grant | 22,000 | -- | -- | 59% 37.53K to 59.53K | |
| 03-Mar-15 4:24 PM View: | Celgene Corporation (CELG) | 01-Mar-15 | Payment of Exercise | 4,321 | $121.53 | $525,131.00 | (5%) 82.09K to 77.77K | 25% |
| 03-Mar-15 4:24 PM View: | Celgene Corporation (CELG) | 01-Mar-15 | Option Exercise | 8,334 | -- | -- | 11% 73.76K to 82.09K | |
| 13-Feb-15 5:07 PM View: | Celgene Corporation (CELG) | 11-Feb-15 | Option Exercise | 27,896 | $37.52 | $1,046,520.00 | 38% 73.75K to 101.65K | |
| 13-Feb-15 5:07 PM View: | Celgene Corporation (CELG) | 11-Feb-15 | Market Option Sale | 27,896 | $120.11 | $3,350,730.00 | (27%) 101.65K to 73.75K | 24% |
| 10-Feb-15 6:49 PM View: | Celgene Corporation (CELG) | 06-Feb-15 | Grant | 30,404 | -- | -- | 52% 58.93K to 89.34K | |
| 10-Feb-15 6:49 PM View: | Celgene Corporation (CELG) | 06-Feb-15 | Payment of Exercise | 15,758 | $118.75 | $1,871,260.00 | (18%) 89.34K to 73.58K | 24% |
| 09-Feb-15 12:42 PM View: | Neoprobe Corp. (NAVB) | 05-Feb-15 | Grant | 7,276 | $1.89 | $13,751.60 | 24% 30.25K to 37.53K | |
| 02-Jan-15 4:01 PM View: | Celgene Corporation (CELG) | 30-Dec-14 | Option Exercise | 23,334 | $29.75 | $694,186.00 | 43% 54.87K to 78.2K | |
| 02-Jan-15 4:01 PM View: | Celgene Corporation (CELG) | 30-Dec-14 | Market Option Sale | 19,273 | $113.37 | $2,184,980.00 | (25%) 78.2K to 58.93K | 20% |
| 14-Nov-14 10:00 PM View: | Celgene Corporation (CELG) | 12-Nov-14 | Option Exercise | 32,074 | $32.90 | $1,055,390.00 | 52% 62.22K to 94.29K | |
| 14-Nov-14 10:00 PM View: | Celgene Corporation (CELG) | 12-Nov-14 | Market Option Sale | 32,074 | $107.23 | $3,439,300.00 | (34%) 94.29K to 62.22K | 15% |
| 14-Nov-14 10:00 PM View: | Celgene Corporation (CELG) | 12-Nov-14 | Market Sale | 7,346 | $107.23 | $787,712.00 | (12%) 62.22K to 54.87K | 15% |
| 12-Nov-14 11:17 AM View: | Neoprobe Corp. (NAVB) | 10-Nov-14 | Grant | 10,252 | $1.32 | $13,532.60 | 51% 20.0K to 30.25K | 54% |
| 05-Aug-14 4:14 PM View: | Celgene Corporation (CELG) | 04-Aug-14 | Option Exercise | 46,450 | $28.16 | $1,308,030.00 | 85% 54.87K to 101.32K | |
| 05-Aug-14 4:14 PM View: | Celgene Corporation (CELG) | 04-Aug-14 | Market Option Sale (Planned) | 39,104 | $87.55 | $3,423,430.00 | (39%) 101.32K to 62.22K | (4%) |
| 05-May-14 6:16 PM View: | Celgene Corporation (CELG) | 01-May-14 | Option Exercise | 11,667 | $59.50 | $694,186.00 | 42% 27.69K to 39.36K | |
| 05-May-14 6:16 PM View: | Celgene Corporation (CELG) | 01-May-14 | Market Option Sale (Planned) | 11,667 | $146.78 | $1,712,480.00 | (30%) 39.36K to 27.69K | (24%) |
| 05-May-14 6:16 PM View: | Celgene Corporation (CELG) | 01-May-14 | Market Sale (Planned) | 255 | $146.78 | $37,428.90 | (< 1%) 27.69K to 27.43K | (24%) |
| 05-Mar-14 4:20 PM View: | Celgene Corporation (CELG) | 03-Mar-14 | Market Sale (Planned) | 2,408 | $159.05 | $382,992.00 | (8%) 29.98K to 27.57K | (14%) |
| 19-Feb-14 11:08 AM View: | Neoprobe Corp. (NAVB) | 17-Feb-14 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 14-Feb-14 4:56 PM View: | Celgene Corporation (CELG) | 12-Feb-14 | Grant | 15,188 | -- | -- | 67% 22.67K to 37.86K | |
| 14-Feb-14 4:56 PM View: | Celgene Corporation (CELG) | 12-Feb-14 | Payment of Exercise | 7,874 | $160.54 | $1,264,090.00 | (21%) 37.86K to 29.98K | (13%) |
| 31-Dec-13 4:26 PM View: | Celgene Corporation (CELG) | 27-Dec-13 | Payment of Exercise | 4,032 | $168.93 | $681,126.00 | (15%) 26.7K to 22.67K | (7%) |
| 31-Dec-13 4:26 PM View: | Celgene Corporation (CELG) | 27-Dec-13 | Option Exercise | 7,777 | -- | -- | 41% 18.92K to 26.7K | |
| 05-Nov-13 4:02 PM View: | Celgene Corporation (CELG) | 01-Nov-13 | Payment of Exercise | 5,185 | $151.30 | $784,516.00 | (22%) 24.11K to 18.92K | (20%) |
| 05-Nov-13 4:02 PM View: | Celgene Corporation (CELG) | 01-Nov-13 | Option Exercise | 10,000 | -- | -- | 71% 14.11K to 24.11K | |
| 02-Aug-13 5:46 PM View: | Celgene Corporation (CELG) | 02-Aug-13 | Payment of Exercise | 12,962 | $147.35 | $1,909,950.00 | (11%) 120.08K to 107.12K | (23%) |
| 02-Aug-13 5:46 PM View: | Celgene Corporation (CELG) | 02-Aug-13 | Option Exercise | 118,008 | $45.02 | $5,312,410.00 | 5701% 2.07K to 120.08K | |
| 02-Aug-13 5:46 PM View: | Celgene Corporation (CELG) | 02-Aug-13 | Market Option Sale | 93,008 | $146.50 | $13,625,700.00 | (87%) 107.12K to 14.11K | (24%) |
| 15-May-15 4:29 PM View: | Celgene Corporation (CELG) | 13-May-13 | Market Option Sale | 6,160 | $115.00 | $708,400.00 | (5%) 113.63K to 107.47K | (58%) |
| 15-May-15 4:29 PM View: | Celgene Corporation (CELG) | 13-May-13 | Market Sale | 41,013 | $115.00 | $4,716,500.00 | (38%) 107.47K to 66.46K | (58%) |